(Reuters) – The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody therapies with emergency use authorization in the United States, according...

People who’ve had Covid-19 are highly unlikely to contract it again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of fight...

THURSDAY, Nov. 5, 2020 — If you’ve recovered from a COVID-19 infection, you can help as many as four other COVID-19 patients get better, simply by donating your plasma. Is it worth it? Just...

Antibodies against the novel coronavirus declined rapidly in the British population during the summer, a study found on Tuesday, suggesting protection after infection may not be long lasting and raising...

Intermediate level: Previous experience in COVID-19-Therapy trials with Plasma A therapy against COVID-19 there is not currently. Scientists in the review of existing drugs for their effectiveness and...